In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Tissue doppler imaging predicts unsuccessfull cardiac rehabilitation after aortic valve replacement in aortic stenosis compared with aortic regurgitation

Session Innovations in exercise training and rehabilitation

Speaker Associate Professor Luminita Iliuta

Event : ESC Congress 2014

  • Topic : preventive cardiology
  • Sub-topic : Rehabilitation: Outcomes
  • Session type : Abstract Session

Authors : L Iliuta (Bucharest,RO)

Authors:
L. Iliuta1 , 1University of Medicine and Pharmacy Carol Davila - Bucharest - Romania ,

Citation:
European Heart Journal ( 2014 ) 35 ( Abstract Supplement ), 47

Aim: 1. To evaluate the ability of TDI measurements to predict unsuccessfull postoperative cardiac rehabilitation (CR) after aortic valve replacement (AVR), comparing aortic stenosis (AS) to aortic regurgitation (AR).

2. To determine the relation between left ventricular (LV) function assessed by TDI and exercise capacity and whether the diastolic and/or systolic dysfunction participate in unsuccessfull CR.

3. To define the independent predictors for unsuccessfull CR and for medium term prognosis/evolution in these pts.

Material and method: Prospective randomized study on 1212 pts undergoing AVR for AS (676pts) or AR (536pts) who underwent postoperative CR (12 weeks of supervised exercise training 3 times/ week). A complete echocardiography (including TDI) was performed before the CR and weekly till 3 months postoperatively. The primary endpoints were the composites of changes in peak oxygen uptake and in physical capacity.

Stastistical analysis used SYSTAT and SPSS for regression analysis and for the relative risks and correlation coefficient calculations.

Results: 1. The percent of the pts with a favourable effect of CR was higher in those with normal LV diastolic filling pattern (LVDFP) (95,09%) compared with pts with restrictive LV filling (77.33%, p<0.0001). The presence of a restrictive LVDFP increased the risk for unsuccessfull CR by 8.2 fold.

2. Before and during the CR, the E/E' ratio was higher in the failed group than in the successfull group. The cut-off value to predict CR failure (obtained from ROC), gave an E/E' ratio before CR of 14.5 with a sensitivity of 77% and a specificity of 95.8% (p<0.01).The LVEF did not differ between the two groups, whereas left and right ventricular TDI velocities were greater in successfull group. E' was lower in the failed group and increased during CR in the successfull group while no change occurred in the failed group.

3. Regression analysis has identified as independent predictors for unsuccessfull CR: E/E' >14.5, late systolic myocardial motion (Sm) <5.5 cm/sec, restrictive LVDFP, age >75 years, AR and LV endsystolic diameter (LVESD) >57 mm.

Conclusions: 1. The presence of a restrictive LVDFP in AVR pts is an independent predictor for unsuccessfull CR, the LV diastolic function being a more reliable parameter for prognosis appreciation than LV systolic function. 2. Sm and E/E' ratio were the only TDi variables independently predicting exercise capacity and related to success of CR program (p<0.05). 3. The independent predictors for unsuccessfull CR were: E/E' >14.5, Sm <5.5 cm/sec, restrictive LVDFP, age >75 years, AR and LVESD >57 mm.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are